The expression of gap junction connexins (Cx) in the female reproductive tract of rodents and in the human endometrium is highly regulated by steroid hormones. Here we have investigated the distribution and regulation properties of Cx43, Cx26 and Cx32 in the human ectopic endometrium of 41 patients, using immunohistochemistry. The biopsies were obtained during the early or late follicular phase (26 cases), during the corpus luteum phase (five cases) and after a 6 month treatment with a gonadotrophin-releasing hormone (GnRH) agonist (three cases) or progestin (seven cases). Aberrant expression of Cx43 was found in the epithelium of nearly all endometriotic glands whereas Cx26, typical for human uterine epithelium cells, was only detected in 18 cases; in 17 it was co-expressed with Cx43. The stromal compartment of the tissues did not express any connexins investigated. Staining for Cx32 was absent in all endometriotic tissues. Strong expression of Cx43 was correlated with a high serum value of 17β-oestradiol, whereas a strong expression of Cx26 was found with high values of progesterone mainly in patients after progestin treatment. The epithelium of endometriotic implants collected after GnRH agonist treatment expressed Cx26 and Cx43 only moderately. The patterns described demonstrate an aberrant connexin expression and a different hormonal regulation pattern in endometriotic tissues compared to the normal cyclic uterine endometrium, thus indicating a high dedifferentiation from the normal situation. However, endometriosis still remains a hormonally-dependent benign disease, and hence, can be treated hormonally.
Introduction
dependent, proliferative but benign disease, only a few investigations have been carried out to study its progressive character Although endometriosis is a well documented disease, first (Dizerga et al., 1980; Walz et al., 1983) . Also the mechanisms described in 1861 by Rokitansky, it remains a complex and involved in the development of endometriosis-associated pain unsolved issue in medical research. The phenomenon of ectopic symptoms are still under investigation. Zahradnik (1995) endometrial tissue has led to many questions concerning the postulated that a local burst of prostaglandins, induced by pathophysiology, aetiology, hormonal regulation properties macrophages and mesothelial cells surrounding endometriotic and, last but not least, appropiate therapy. The complexity of implants, seems to be involved in this process. the different types of endometriotic lesion makes it difficult
The management of women with endometriosis is complex, to compare different studies dealing with the therapeutic due to the fact that this disorder is not well defined and lacks approaches to this disease. Therefore, the applied therapies are appropiate cell biological markers. In normal endometrial in part contradictionary (for review see Wingfield and Healy, tissue several markers including integrins (Lessey et al., 1994 (Lessey et al., ) 1993 . Endometriosis is found in~8-12% of sexually mature and gap junctions have been described for women and is combined with dysmenorrhoea, with cyclic or an appropiate differentiation related to the menstrual cycle. In acyclic chronical pain and/or dyspareunia (Barbieri, 1988;  this study we have focused on the expression pattern and Schweppe et al., 1990; Schindler, 1995) . In~30-40% of cases, hormonal regulation properties of different gap junction proendometriosis seems to be responsible for sterility (Kistner, teins, connexins (Cx) , in endometriotic tissues. Connexins 1979). Different theories on the origin and pathogenesis of this belong to a multigene family, of which 13 members in the disease have been developed throughout the years, including murine genome have already been cloned (Willecke, 1993) . retrograde menstruation (Sampson, 1921) , migration via the All of these different channels seem to exhibit different vascular or lymphatic system (Halban, 1925; Staffeld, 1968) physiological properties including voltage gating and conductor remnants of the Müllerian ducts as well as neoplastic ance, as well as the possibility of a different dye transfer (for dedifferentiation from mesothelial cells (Meyer, 1903; Geipel, review see Waltzmann and Spray, 1993) . Direct cell-cell 1927). The most supported concept, however, is that endocommunication seems to be involved in coordinating proliferametriosis is derived from a retrograde menstruation in combination and differentiation processes, probably mediated through tion with a defect in the immune system (Leyendecker et al., 1995) . Though endometriosis is probably a hormoneexchange of second messengers such as cAMP, inositol 1,4,5-trisphosphate (IP 3 ) as well as Ca 2ϩ (Saez et al., 1989) . humans, the spatial and temporal pattern of gap junctional proteins is precisely regulated in relation to the hormonal Connexin expression is normally found in adult tissue in a steady state situation. In the target organs of steroid hormones, status of the cycle . Cx26, which is expressed in the uterine epithelium, and Cx43 which is seen between the connexins seem to be highly regulated. This has been extensively studied in the myometrial compartment of the uterus of stromal cells, are down-regulated during the luteal phase and dramatically increase during the oestrogen-dominated phase several species (Garfield et al., 1980 (Garfield et al., , 1981 Sakai et al., 1992; Petrocelli and Lye, 1993; Piersanti and Lye, 1995) . In the of the menstrual cycle. The loss of cell-cell communication as well as an myometrium, the increase of oestrogen and the decrease of progesterone serum concentrations seems to be responsible for inappropiate expression of connexins may be responsible for dedifferentiation processes leading to tumorigenesis the induction of gap junctions prior to term to synchronize muscle contraction at birth (Garfield et al., 1988) . (Yamasaki, 1991) . This is supported by several investigations (Wilgenbus et al., 1992; Holder et al., 1993) which have A similar regulation of connexins by 17β-oestradiol and progesterone could be shown in the endometrium of several shown that tumorigenesis is correlated with aberrant or low connexin expression or a chemically-induced suppression of species during the pre-and peri-implantation phase (Winterhager et al., 1988 (Winterhager et al., , 1991 Grümmer et al., 1994) . In cell-cell communication (Yamasaki et al., 1995) .
Immunohistochemistry
The characterization of cell biological markers specific for
Cryostat sections (4-7 µm) were fixed in ice-cold absolute ethanol endometrial differentiation may elucidate the mechanisms for 5-10 min. An affinity purified rabbit monoclonal antibody to involved in the pathogenesis of endometriosis and could give
Cx26 from mouse liver gap junctions (Traub et al., 1989) , a rat some help for an appropiate medical treatment. Here we studied monoclonal antibody against Cx32 of mouse liver gap junctions the expression pattern and hormonal regulation properties of (Janssen-Timmen et al., 1986 ) and a monoclonal mouse antibody to connexins in the ectopic glandular uterine epithelium to gain Cx43 (Affinity, Cambridge, UK) were used as primary antibodies.
an insight into the extent of dedifferentiation and hormonal
Immunohistochemical staining was performed as described previously regulation of endometriotic tissue. (Winterhager et al., 1991) . Briefly, slides were rinsed in a phosphate-buffered saline/bovine serum albumin (PBS/BSA) buffer for 10 min before incubation with
Material and methods
the primary antibodies in a dilution of 1:40 for 90 min at room temperature in a humidity chamber. Incubation with a secondary Patients and therapies anti-mouse and anti-rabbit antibody conjugated with fluorescein Samples from human endometriotic lesions located in the peritoneum isothiocyanate (FITC) at a dilution of 1:40 was then carried out for were collected from 41 women at the Department of Gynaecology at 45 min. After washing, the slides were covered with glycerol the University of Essen, Germany, between 1994 and 1995. In all, containing 0.1% paraphenylenediamine to avoid photobleaching. 17 patients suffered from infertility, 16 from endometriosis-associated Negative controls were obtained by substituting the primary antipain symptoms, including dysmenorrhoea, dyspareunia and chronic body with preimmune rat serum or mouse immunoglobulin (Ig)G. pelvic pain, and eight from both. The improvement of the endoFor positive controls, samples of human tissues were used which had metriosis-associated pain symptoms was evaluated after gonadotroa known strong expression (human liver for Cx32 and Cx26 and phin-releasing hormone (GnRH) agonist or progestin therapy using a human heart tissue for Cx43). Because of the small diameter of the specific questionnaire that was given to the patients.
endometriotic lesions (~2 mm), the complete slice of tissue was Tissue samples were obtained by laparoscopy, snap frozen in liquid examined and microscopically evaluated. Two slides were analysed for nitrogen and stored at -20°C. Biopsies were taken during the early each class of connexin molecule and each type of endometriotic tissue. and the late proliferative phase (n ϭ 26) or during the luteal phase
The intensity of connexin staining was semiquantitative: strong (n ϭ 5) of the menstrual cycle. In three cases samples were collected (ϩϩϩ), moderate (ϩϩ), low (ϩ) or negative (-). This semiquantitafter a 6 month treatment with a GnRH agonist (Leuprorelinacetate; ative evaluation of the slides was determined using the IR score of Takeda Pharma, Aachen, Germany) given in a dosage of 3.75 mg Remmele and Stegner (1987) which takes the staining intensity (SI) i.m. every 4 weeks and in seven cases after 6 months of treatment and the percentage of positive cells or cell membranes (PP) into with the progestin dienogest (Jenapharm, Jena, Germany) given in a consideration. The staining intensity is subdivided into: 0 ϭ no dosage of 2 mg orally daily. staining intensity; 1 ϭ low staining intensity; 2 ϭ moderate staining intensity; 3 ϭ strong staining intensity.
Hormone analyses
The percentage of cells expressing connexin was subdivided as For all patients, serum concentrations were evaluated for 17β-follows: 1 ϭ 1-10% positive cells; 2 ϭ 11-50% positive cells; 3 ϭ oestradiol, progesterone, follicle stimulating hormone (FSH) and 51-80% positive cells; 4 ϭ 81-100% positive cells. luteinizing hormone (LH) shortly before surgery. 17β-oestradiol
The multiplication of the points given for staining intensity and and progesterone were measured using a commercially available percentage of positive cells yields the IR score. We used a score of radioimmunoassay (Sorin Biomedica, Saluggia, Verucelly, Italy). FSH 2 points as a cut-off-point between connnexin-positive and negative and LH were determined by an enzyme-linked immunosorbent assay cells, i.e. IRS values of 0 and 1 point were considered as connexin negative, values between 2 and 4 were considered as low positive (Johnson and Johnson, Norderstedt, Germany). detected in the ectopic epithelium of 18 samples (Figure 3) . Except for one case, Cx26 was found co-expressed with Cx43.
Statistical analyses
The expression of Cx26 was usually lower than the expression Statistical analyses were performed using the SAS program (SAS of Cx43 as shown in Table I . The epithelial cells which Institute, 1985) for the correlation of the 17β-oestradiol and progesterexpressed Cx26 in addition to Cx43 were morphologically one values with the expression of Cx43 and Cx26 respectively. The characterized by a cylindrical shape indicating a more differen-χ 2 , the likelihood ratio χ 2 , the Mantel-Haenszel χ 2 , the π coefficient, tiated feature. Cx32 staining was not found in any endometriotic the contingency coefficient and Cramer's V test were used. The level tissue, epithelium or stroma, respectively (Figure 4 ). Surprisof significance was set at P Ͻ0.05.
ingly, in all the samples, none of the stromal cells surrounding the glands of the endometriotic implants expressed any of the
Results

connexins investigated (Figure 5). Modulation of the connexin expression pattern of the ectopic
In contrast, the uterine epithelial cells of normal cyclic implants was found to be dependent on the oestrogen and human endometrium expressed Cx26 during the oestrogenprogesterone serum concentrations of the individual patients, dominated phase and, to some extent, Cx32 but never Cx43, regardless of whether they were hormonally treated or not.
which is exclusively found in the stromal compartment (Jahn In general, Cx43 was preferentially expressed in the glanduet al., 1995) (Figure 6 ). Table I shows the distribution pattern lar epithelium of endometriotic tissues of nearly all patients of Cx43, Cx26 and Cx32 of the 41 patients, their serum (40 from 41) independent of either the hormonal phase or concentrations of 17β-oestradiol and progesterone and the relationship with hormonal treatment in 10 cases. treatment; Figure 1 shows a low Cx43 expression (ϩ) and Hormonal regulation of connexin expression in endometriosis 17β-oestradiol As summarized in Figure 7 , high concentrations of 17β-oestradiol (Ͼ100 pg/ml) at the time of surgery were correlated with a high level of expression of Cx43. The three patients with a strong expression (ϩϩϩ) for Cx43 revealed 17β-oestradiol concentrations of 150, 152 and 110 pg/ml respectively. In patients with 17β-oestradiol concentrations of 50-100 pg/ml the Cx43 expression in the ectopic glandular epithelium was low (ϩ) in 12 cases and moderate (ϩϩ) in two cases. Patients with 17β-oestradiol concentrations Ͻ50 pg/ml (13 cases) showed in only one case a moderate (ϩϩ) expression of Cx43, whereas 11 patients showed only a low (ϩ) expression of Cx43. In the single case where no Cx43 Table I ) and their endometriosis-associated pain very low (12 pg/ml). symptoms in relation to progesterone concentrations and gestagen
The three patients treated for 6 months with the GnRH therapy; n ϭ 18. agonist leuprorelinacetate had a significant suppression of the ovarian function (17β-oestradiol concentration Ͻ30 pg/ml and 192, P Ͻ0.05). Cx43 was clearly down-regulated. Three of progesterone concentration Ͻ0.3 ng/ml) and were included in these patients had received therapy with progestin dienogest the group with 17β-oestradiol Ͻ50 pg/ml. The endometriotic for 6 months. The only patient of our study with negative implants showed not only a regressive morphology and an Cx43 expression had also received 6 month therapy with 2 mg endothelial like glandular epithelium, but expressed Cx43 only dienogest. All the patients that received progestin treatment in a low (ϩ) amount. Cx26 could only be found in one of (seven patients; see Figure 9 ) experienced a significant these three patients, also in a low (ϩ) amount, thus suggesting improvement of their pain symptomatology. Nevertheless, in that suppression of ovarian function leads to a minimal contrast to the three GnRH agonist treated patients, progestin expression of connexins. These three patients showed no therapy did not reduce the objective extension of the endomeendometriosis associated pain symptoms after therapy and had triosis, so that the implants had to be removed surgically (postonly minimal endometriotic residuals [post-treatment revised treatment revised AFS scores of II and/or III). American Fertility Society (AFS, 1985) score of I].
There was one patient who had a progesterone value Ͼ1 All the correlations between the 17β-oestradiol concentrang/ml but no Cx26 staining. In this case the 17β-oestradiol tions and Cx43 expression were statistically significant (χ 2 13 value was 122 pg/ml. Progesterone values Ͻ1.0 ng/ml were 253; P Ͻ0.05).
correlated with a negative result for Cx26 expression.
A combination between the expression of Cx26 in the Progesterone As shown in Figure 8 the intensity of Cx26 immunostaining ectopic glandular epithelium and endometriosis-associated pain symptoms was observed. As shown in Figure 9 , only four of in the ectopic glandular epithelium was clearly correlated with the progesterone concentrations (0.11-5.9 ng/ml). Seven of the 18 patients with a positive Cx26 immunostaining had endometriosis-associated pain symptoms. The remaining 14 the 18 patients with a progesterone value ജ1.0 ng/ml had a low positive or moderate positive Cx26 staining (χ 2 value 10 patients had no endometriosis-specific pain symptoms.
Discussion
dedifferentiation process and is correlated with the development of pain. The present study deals with the expression pattern of gap It has been shown that dedifferentiation processes mainly junction connexins in endometriotic implants of patients under involved in the multistep processes of carcinogenesis are different hormonal situations. While the uterine epithelium of correlated with aberrant or low expression of connexins normal cycling patients expresses Cx26 and to a low extent, (Yamasaki et al., 1995) . The proof that appropriate tissueCx32, the epithelium of endometriotic glands demonstrates an specific intercellular communication is involved in regulation aberrant expression of Cx43. Only more differentiated ectopic of cell growth and control of differentiation has been provided endometrial glands with a cylindrical epithelium show the by experiments using tumour and neoplastic cell lines transappropriate Cx26 protein in addition to Cx43 (Winterhager fected with different connexin genes. Mesnil et al. (1995 Mesnil et al. ( ) et al., 1993 Jahn et al., 1995) . The stromal cells, normally demonstrated a significantly reduced growth of HeLa cells in expressing Cx43, lacked the connexins studied in the endoculture as well as in nude mice when transfected with Cx26. metriotic implants. It has been shown in several reports that Chen et al. (1995) found that neoplastic kidney cells transfected gap junctional connexins are hormonally regulated in the with Cx43 had reduced proliferation accompanied by a decrease endometrium during preimplantation in rats (Grümmer et al., in cell cycle regulatory elements including cyclins A, D1 and 1994) as well as during the menstrual cycle in humans (Jahn D2 . This points to the fact that a tissue-specific connexin et al., 1995) .
expression is important for regulation of coordinated proliferaAlthough the connexin expression in the endometriotic tion. In this context the aberrant expression of Cx43 and of implants was aberrant, this work suggests that it is still under Cx26 could probably reflect the progressive extension of hormonal control. As in normal endometrium, Cx43 expression endometriosis. in the epithelium is enhanced in the presence of elevated Thus the pain relief correlated with endometriotic tissue oestrogen serum concentrations. Cx26 regulation, however, characterized by Cx26 expression could explain the positive does not seem to follow the same rules as described for normal subjective development of endometriosis-associated pain cycling endometrium. Cx26 expression in endometriotic gland symptoms in patients treated with progestins in controlled epithelium is correlated with higher progesterone serum values studies (Kouridis and Kistner, 1968; Moghissi, 1976) . Due to even after progestin treatment which normally suppresses this the loss of cell-cell communication in the stroma as well as gene (Grümmer et al., 1994; Jahn et al., 1995) . These different an inappropriate expression of connexins, endometriosis can regulation properties of Cx26 between normal and endometrialso be described as a disease which undergoes both prootic tissue could be caused by the abnormal expression of liferative and dedifferentiation processes. Therefore, our data oestrogen and progesterone receptors in ectopic glands. In confirm the clinical observations of Malinak et al. (1992) and contrast to the uterine endometrium, a lower concentration for Walz et al. (1983) who showed that endometriosis exhibits a both receptor types were found in the epithelium as well as in progressive character. That means that endometriosis should the stromal compartment (Regidor et al., 1994) . The aberrant not be underestimated and considered as a disease that has to connexin expression also could explain the findings of be treated either surgically and/or hormonally to avoid its Schweppe and Wynn (1981) , which showed that endometriotic progressive development. implants did not undergo cyclical changes compared with the Nevertheless, additional markers specific for appropriate corresponding endometrium. differentiation of human endometrium such as integrins (Lessey Interestingly, the patients with higher progesterone serum et al., 1994), CD44 (Regidor et al., 1996) or E-cadherin (van concentrations showed no clinical endometriosis-associated der Linden et al., 1994) have to be studied in endometriotic pain symptoms. One can speculate that the progestin-induced implants under therapy to understand the complex dedifferentidifferentiation of the endometriotic implants leads to a consecation process as well as differentiation properties of endoutive loss of the ability to induce prostaglandin secretion, and metriosis. This could help to develop individual therapeutic hence pain, by the surrounding macrophages and mesothelial concepts in the treatment of endometriosis. cells.
Patients treated with GnRH agonists showed a complete down-regulation of the connexins studied and also showed a
